Month: August 2025
Faraday Future Reports Financial Results for Second Quarter 2025Faraday Future Reports Financial Results for Second Quarter 2025Q2 adjusted operating loss stood at approximately $27.4 million, with a monthly average of $9 million during this quarter; Quarter-end cash position reached an 18-month high; Operating efficiency and cost control continued to strengthen.
Officially added to the Russell 3000 Index—a key milestone that enhances visibility and credibility among institutional investors, analysts, and the broader market.
Top-tier international fund managers continued to increase their holdings in FFAI. Vanguard and BlackRock both increased their holdings in FFAI by over 500%, compared with Q4 2024.
Announced that Mariah Carey, the best-selling female artist of all time and global top music legend, will become the next owner...
Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio
Written by Customer Service on . Posted in Public Companies.
Mowad-Nassar is Senior Vice President at AbbVie and President, Specialty and U.S. Therapeutics Operations
Her appointment brings over 30 years of strategic, commercial, and operational expertise in the pharmaceutical and broader healthcare industry, with a focus on digital innovationSAN DIEGO, Aug. 18, 2025 (GLOBE NEWSWIRE) — Resmed (NYSE: RMD, ASX: RMD) today announced the election of Nicole Mowad-Nassar to its board of directors, effective August 15, 2025. The company also announced that board member Rich Sulpizio is thanked for two decades of contributions to Resmed, and will retire from the board, not standing for reelection at the 2025 Annual Meeting of Stockholders, scheduled for November 19, 2025.
Nicole Mowad-Nassar currently serves as President of Specialty and U.S. Therapeutics Operations at AbbVie. She leads a $6...
Iovance’s Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma
Written by Customer Service on . Posted in Public Companies.
First T cell therapy for a solid tumor cancer and first treatment option approved in Canada for advanced melanoma after anti-PD-1 and targeted therapy
SAN CARLOS, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced Health Canada has issued a Notice of Compliance with Conditions (NOC/c) for Amtagvi® (lifileucel), a tumor-derived autologous T cell immunotherapy. Amtagvi is indicated for the treatment of adult patients with unresectable or metastatic melanoma that has progressed on or after at least one prior systemic therapy including a PD-1 blocking antibody, and if BRAF V600 mutation positive, a BRAF inhibitor...
TILT Holdings Announces Closing on Sale of Massachusetts Dispensaries to In Good Health
Written by Customer Service on . Posted in Mergers And Acquisitions.
SCOTTSDALE, Ariz., Aug. 18, 2025 (GLOBE NEWSWIRE) — TILT Holdings Inc. (“TILT” or the “Company”) (Cboe CA:TILT) (OTCID: TLLTF), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, announced today the closing of the sale of two of its Massachusetts dispensaries to In Good Health. The definitive agreement for this transaction was previously announced on February 3, 2025. Simultaneously, with the closing, the parties entered into an amendment adjusting the purchase price to $1.75 million.
The retail transaction is part of TILT’s overall strategic alternatives review. Under the terms of the transaction for the two stores, In Good Health will operate the Taunton location going forward and the Brockton dispensary was shut down.
Highgate...
Fabrinet Announces Fourth Quarter and Fiscal Year 2025 Financial Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Record Fourth Quarter Revenue Exceeds Guidance Range
Record Fiscal Year 2025 Revenue Increases 19% Year-over-yearBANGKOK, Aug. 18, 2025 (GLOBE NEWSWIRE) — Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, today announced its financial results for its fourth quarter and fiscal year ended June 27, 2025.
Seamus Grady, Chief Executive Officer of Fabrinet, said, “Our fourth quarter was exceptional, capping off a remarkable year with strong momentum. We achieved record quarterly revenue of $910 million, exceeding our guidance range. Through excellent execution, our non-GAAP EPS also reached a new all-time high. For all of fiscal year 2025, we achieved record revenue of $3.4 billion,...
First Advantage Releases Fourth Annual Sustainability Impact Report
Written by Customer Service on . Posted in Public Companies.
The 2024 Report Highlights Progress in Environmental, Community, and Governance Priorities Amid Transformational Growth
ATLANTA, Aug. 18, 2025 (GLOBE NEWSWIRE) — First Advantage Corporation (NASDAQ:FA), a leading provider of global software and data in the HR technology industry, today announced the release of its 2024 Sustainability Impact Report. The fourth annual report outlines the company’s continued commitment to responsible business practices and transparent progress across key environmental, community, and governance priorities.
The 2024 report records a milestone year for First Advantage, marked by its acquisition of Sterling Check Corp., that closed on Oct. 31, 2024. Throughout this period of growth, First Advantage reaffirmed its sustainability focus areas: people and community, environment and climate, governance and...
$10,000 in Cash Up for Grabs in F&M Bank’s “The Great Briefcase Hunt”
Written by Customer Service on . Posted in Public Companies.
Six clues. One hidden briefcase. A community adventure with big rewardsARCHBOLD, Ohio, Aug. 18, 2025 (GLOBE NEWSWIRE) — F&M Bank (“F&M”), an Archbold, Ohio-based bank owned by Farmers & Merchants Bancorp, Inc. (Nasdaq: FMAO), is inviting the community to put on their detective hats for a high-stakes summer challenge, $5,000 for a lucky hunter and $5,000 for a local charity.
The Great Briefcase Hunt kicked off Monday, August 18, 2025, and dares residents across the F&M footprint to follow a series of weekly clues leading to a hidden briefcase in a local park.
“It’s time to join the hunt,” said Amy Cover, Chief Marketing Officer at F&M Bank. “We are creating an adventure that sparks excitement, brings people outside, connects neighbors, and delivers a huge ‘wow’ moment when that briefcase is finally found....
TOFUTTI ANNOUNCES RESULTS FOR THE THIRTEEN AND TWENTY-SIX WEEKS ENDED JUNE 28, 2025
Written by Customer Service on . Posted in Public Companies.
Edison, New Jersey, Aug. 18, 2025 (GLOBE NEWSWIRE) — TOFUTTI BRANDS INC. (OTCQB Symbol: TOFB) issued its results for the thirteen and twenty-six weeks ended June 28, 2025 and June 29, 2024 today.
Tofutti Brands reported net sales for the thirteen weeks ended June 28, 2025 decreased by $254,000, or 11%, from net sales of $2,283,000 for the thirteen weeks ended June 29, 2024 to $2,029,000 for the thirteen weeks ended June 28, 2025. Sales of our vegan cheese products decreased to $1,708,000 in the thirteen weeks ended June 28, 2025 from $1,926,000 in the thirteen weeks ended June 29, 2024, due to increased competition in the vegan cheese category. Sales of our frozen dessert products decreased to $321,000 in the thirteen weeks ended June 28, 2025 from $357,000 for the thirteen weeks ended June 29, 2024. Our sales were also negatively...
HCW Biologics Reports Second Quarter 2025 Business Highlights and Financial Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
MIRAMAR, Fla., Aug. 18, 2025 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between inflammation and age-related diseases, today reported financial results and recent business highlights for its second quarter ended June 30, 2025.
On May 15, 2025, the Company closed an equity offering with gross proceeds of $5.0 million with a single institutional investor. Dr. Hing Wong, Founder and CEO, stated, “We are pleased to have completed a successful $5.0 million equity offering in a challenging market without using a highly structured deal. This funding will be used to open clinical sites for our Phase 1 clinical trial to evaluate HCW9302 in an...
Terra Balcanica Intersects Gold Mineralization Over 72 m and Starts Drill Program At Brezani Target in Bosnia
Written by Customer Service on . Posted in Public Companies.
Vancouver, British Columbia, Aug. 18, 2025 (GLOBE NEWSWIRE) — Terra Balcanica Resources Corp. (“Terra” or the “Company”) (CSE:TERA; FRA: UB1) is pleased to announce an expansion of the surface gold skarn system at Brezani and the start of the Phase III drill program at its Viogor-Zanik project, Bosnia and Herzegovina.
HighlightsThe Brezani drillhole BRE23001 located 125 m SSW of the maiden Brezani drillhole intercepted 0.27 g/t Au over 72.3 m including 0.62 g/t Au over 7.5 m. Additionally, two antimony veined zones, 1.5 and 0.5 m wide were intersected, respectively (Figure 2);The drillhole BRE23002 located 145 m northwest of BRE23001 intercepted 1.51 Zn% over 6 m including 0.54% Sb over 1.65 m as well as 0.6 g/t Au over 2.85 m;The drillhole BRE23003 located 77 m southeast of the maiden Brezani drillhole encountered 0.19%...
